Filana Therapeutics Legal Notice

The statements within the Filana Therapeutics, Inc.’s website relating to Filana's products in development, technology attributes or capabilities, product development plans, development timelines, expected product or technology benefits or potential product markets are forward-looking and involve risks and uncertainties that could cause actual results to differ materially from those. Potential risks and uncertainties include, but are not limited to, the risks inherent in the development and testing of drug candidates, including the risk that clinical trials may be unsuccessful; the potential for unexpected adverse side effects or inadequate therapeutic efficacy of our drug candidates; the risk that we may be unable to obtain product approvals from regulatory agencies; the uncertainty of patent protection for our intellectual property or trade secrets; potential unanticipated additional research and development, litigation and other costs; challenges associated with the need to raise additional funding from time-to-time; and the potential for competing products to be developed by competitors, potential competitors or others. Further information regarding these and other risks is included in the company's quarterly reports on Form 10-Q and annual report on Form 10-K, as filed with the SEC. Copies of these documents are available on request from the Investor Relations Department of Filana.

No Duty to Update

The information contained in this website was current as of the date posted. The company assumes no duty to update the information to reflect new information or subsequent developments. Consequently, investors should not rely upon the information as current or accurate after the date it was posted.